Daewon Pharmaceutical Co., Ltd. (KRX:003220)
13,450
+140 (1.05%)
At close: Nov 14, 2025
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 288.28 billion as of November 14, 2025. Its market cap has decreased by -12.83% in one year.
Market Cap
288.28B
Enterprise Value
434.75B
Revenue
603.74B
Ranking
n/a
PE Ratio
31.47
Stock Price
13,450.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 288.28B, an increase of 1,496.24%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 288.28B | -5.61% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | 380.71B | 13.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 43.20T |
| ALTEOGEN | 29.63T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.60T |
| Yuhan | 9.35T |
| Peptron | 7.22T |
| HLB Co., Ltd. | 6.50T |